In Exp. 1, carried out in September 1969, oestrous cycles of eighteen Angus and Hereford cows, 18 to 20 months old, were suppressed with 0\m=.\5 mg melengestrol acetate (MGA\p=m-\TheUpjohn Co., Kalamazoo)/cow/day for 18 days. Four days before the end of MGA treatment, 1500 to 3000 i.u. pmsg were given to induce multiple ovulation. The cows were fasted for 3 days after the pmsg injection to reduce excessive follicular development . Thirteen cows which came into oestrus on the 3rd day after cessation of hormonal treatments were studied. Each cow was mated to two bulls. Ten days later, the number of cl was determined by use of an endoscope (Lamond & Holmes, 1965 (Hill, Lamond, Henricks, Dickey & Niswender, 1970) , except that a pool of luteal phase cow plasma containing 3-3 ng/ml was used as an internal standard. The potency of the laboratory standard was established both by repeated assay using the CPB assay and by one analysis using gas-liquid chromatography. Plasma samples from beef cows were assayed in random order. Use of the laboratory standard at three dilutions not only provided a test for the reliability of the CPB assay but also saved time when evaluating plasma samples containing manifold differen¬ ces in progesterone concentrations because it was possible to use classical (Cox, 1970 It is well established that intramuscular injection of 30 mg to 50 mg pro¬ gesterone daily will suppress ovarian cycles in cows (Lamond, 1964) . Imori (1967) observed plasma levels of 11-5 ng/ml and 17-7 ng/ml 4 hr after a sub¬ cutaneous injection of 2 g progesterone into two cows. Data obtained by Gaddy and Lamond (unpublished observations) and Henricks & Lamond (1972) indicate that doses of 50 to 200 mg progesterone produce plasma concentration peak values of 2 to 8 ng progesterone/ml in 4 to 12 hr. These levels may be maintained by injections repeated daily or every 2 days. To obtain blood levels comparable to those found in some multiple ovulating heifers, it would appear to be necessary to inject physiologically enormous doses of progesterone which might adversely affect the ability of the uterus to nourish embryos. 
